US EditionPublished • loading... • Updated
A New Cell Therapy Offers Promising Results in Women with Asherman Syndrome
Summary by Salud a Diario
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Salud a DiarioReposted by 
RUVID
RUVIDThe study, led by the Instituto de Investigación Sanitaria INCLIVA-Fundación Carlos Simón and the company Endorenew and published in the journal Nature Communications, presents the results of a phase 1 and 2 combined clinical trial (designed to assess, on the one hand, the safety of treatment and, in parallel, to explore its first clinical effects) carried out in women who had not responded to conventional surgical treatments. The study included…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
